A detailed history of Center For Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Center For Asset Management LLC holds 2,761 shares of AMGN stock, worth $876,589. This represents 0.51% of its overall portfolio holdings.

Number of Shares
2,761
Previous 2,715 1.69%
Holding current value
$876,589
Previous $771,000 11.8%
% of portfolio
0.51%
Previous 0.63%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$262.75 - $319.31 $12,086 - $14,688
46 Added 1.69%
2,761 $862,000
Q1 2024

Apr 25, 2024

SELL
$268.87 - $324.56 $3,764 - $4,543
-14 Reduced 0.51%
2,715 $771,000
Q4 2023

Jan 22, 2024

SELL
$255.7 - $288.46 $51,907 - $58,557
-203 Reduced 6.92%
2,729 $786,000
Q3 2023

Oct 27, 2023

SELL
$218.65 - $271.46 $6,996 - $8,686
-32 Reduced 1.08%
2,932 $788,000
Q2 2023

Jul 24, 2023

BUY
$214.27 - $253.37 $44,568 - $52,700
208 Added 7.55%
2,964 $658,000
Q1 2023

Apr 24, 2023

BUY
$225.79 - $275.2 $146,763 - $178,880
650 Added 30.86%
2,756 $666,000
Q4 2022

Jan 23, 2023

SELL
$229.03 - $291.01 $284,913 - $362,016
-1,244 Reduced 37.13%
2,106 $0
Q3 2022

Oct 21, 2022

BUY
$224.46 - $253.15 $221,093 - $249,352
985 Added 41.65%
3,350 $755,000
Q2 2022

Jul 20, 2022

BUY
$230.71 - $256.74 $171,878 - $191,271
745 Added 45.99%
2,365 $575,000
Q1 2022

Apr 26, 2022

BUY
$219.27 - $242.57 $56,790 - $62,825
259 Added 19.03%
1,620 $392,000
Q4 2021

Jan 12, 2022

BUY
$198.88 - $227.6 $72,790 - $83,301
366 Added 36.78%
1,361 $306,000
Q3 2021

Nov 01, 2021

BUY
$212.27 - $248.7 $29,293 - $34,320
138 Added 16.1%
995 $212,000
Q2 2021

Aug 06, 2021

BUY
$233.58 - $259.14 $200,178 - $222,082
857 New
857 $209,000
Q1 2021

Apr 28, 2021

SELL
$221.91 - $258.6 $221,910 - $258,600
-1,000 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$216.38 - $257.67 $216,380 - $257,670
1,000 New
1,000 $230,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $170B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Center For Asset Management LLC Portfolio

Follow Center For Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center For Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Center For Asset Management LLC with notifications on news.